You are required to be logged in to access the full website
Click here if you have forgotten your username or password
4 October 2024 - Molecular diagnostics company Exact Sciences Corp. (NASDAQ:EXAS) announced on Friday that it has received FDA approval for its next-generation multitarget stool DNA test, Cologuard Plus.This test is approved for adults aged 45 and ol...
4 October 2024 - Biotechnology company Amyris announced on Thursday that it has been awarded an agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C) for USD12.3m from the Administration for Strategic Preparedness a...
4 October 2024 - Biotech company ABL Bio announced on Friday that it has signed a clinical trial collaboration and supply agreement with MSD, a subsidiary of US-based Merck & Co., Inc.Under the agreement, the companies are to assess ABL103 in com...
3 October 2024 - Biopharmaceutical company Avidity Biosciences Inc (Nasdaq: RNA) said on Thursday that the US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC 1001).This investigation...
3 October 2024 - Privately owned specialty biopharmaceutical group Ferring Pharmaceuticals announced on Thursday that it has opened a new manufacturing facility in Finland for the drug substance of its intravesical non-replicating gene therapy Adstil...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe